A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for the prophylaxis of migraine in pediatric subjects 12 to 17 years of age.

Trial Profile

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for the prophylaxis of migraine in pediatric subjects 12 to 17 years of age.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Sep 2017

At a glance

  • Drugs Topiramate (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jan 2010 Patient numbers amended from 103 to 110 as reported by ClinicalTrials.gov.
    • 01 Mar 2009 Results published in Pediatrics.
    • 26 Jun 2008 Results have been presented at the 50th Annual Scientific Meeting of the American Headache Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top